Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.

The malaria vaccine candidate, RTS,S/AS01(E), showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability. The experimental design was a Phase 2b, two-centre, double-blind (observer- and participan...

Повний опис

Бібліографічні деталі
Автори:	Lusingu, J, Olotu, A, Leach, A, Lievens, M, Vekemans, J, Olivier, A, Benns, S, Olomi, R, Msham, S, Lang, T, Gould, J, Hallez, K, Guerra, Y, Njuguna, P, Awuondo, K, Malabeja, A, Abdul, O, Gesase, S, Dekker, D, Malle, L, Ismael, S, Mturi, N, Drakeley, C, Savarese, B, Villafana, T, Ballou, W, Cohen, J, Riley, E, Lemnge, M, Marsh, K, Bejon, P, von Seidlein, L
Формат:	Journal article
Мова:	English
Опубліковано:	Public Library of Science 2010

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.

Схожі ресурси